Patients positive for anti-CCAR1 antibodies were diagnosed with cancer significantly later compared with anti-CCAR1–negative patients (median time from DM onset 4.3 vs. 0.85 years, respectively; P = 0.006). Here, CCAR1 is linked to dermatomyositis.